It wasn’t so long ago that Bernie Sanders (I-VT) comfortably occupied the left flank of health care policy. His Medicare For All bill was sufficiently costly, coercive and utopian to set him apart from the pack. Times have changed. When it comes to drug pricing, Bernie faces unexpected intruders on his left: Republicans. In recent months, Bernie has yielded socialist turf to two … [Read more...] about GOP May Outflank Bernie on Drug Price Controls
Doug Badger
Examination of International Drug Pricing Policies in Selected Countries Shows Prevalent Government Control over Pricing and Restrictions on Access
Report Extract: The Trump Administration has proposed using its demonstration authority under section 1115A of the Social Security Act to test a method of reimbursement for physician-administered drugs based on prices in 14 countries. The proposal is controversial, raising constitutional questions about the agency’s authority to modify Medicare reimbursement absent congressional action, as well … [Read more...] about Examination of International Drug Pricing Policies in Selected Countries Shows Prevalent Government Control over Pricing and Restrictions on Access
The Facts About the Individual Mandate Repeal and the Increase in Premiums
by Doug Badger — It turns out sabotage might be overrated. A new study by the Center for American Progress argues Congress’s repeal of the individual mandate and a proposed Trump administration rule that would expand the sale and renewal of short-term policies will have a devastating effect on 2019 premiums. These acts of “sabotage” mean 40-year-old non-smokers will pay an average of … [Read more...] about The Facts About the Individual Mandate Repeal and the Increase in Premiums